Vivelle and Ritalin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vivelle (estradiol) and Ritalin (methylphenidate hydrochloride). Common drug interactions include migraine among females.

The phase IV clinical study analyzes what interactions people have when they take Vivelle and Ritalin. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Vivelle?

Vivelle has active ingredients of estradiol. It is often used in hormone replacement therapy. eHealthMe is studying from 6,624 Vivelle users. Check the latest studies of Vivelle.

What is Ritalin?

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,427 Ritalin users. Check the latest studies of Ritalin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

70 people who take Vivelle and Ritalin together, and have interactions are studied.

What are the common drug interactions of Vivelle and Ritalin, by gender? *:

female:

Migraine (headache)
Fall
Sciatic nerve injury
Vision blurred
Abnormal dreams
Adverse drug reaction
Dizziness
Infusion related reaction
Pain
Urticaria (rash of round, red welts on the skin that itch intensely)

male:

n/a

What are the common drug interactions of Vivelle and Ritalin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Dyspnoea (difficult or laboured respiration)
Gait disturbance
Headache (pain in head)
Nervousness
Pain
Terminal insomnia (a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired)

40-49:

Muscular weakness (muscle weakness)
Irritable bowel syndrome
Surgery
Asthenia (weakness)
Blood pressure increased
Disturbance in attention
Dyskinesia (abnormality or impairment of voluntary movement)
Fatigue (feeling of tiredness)
Heart rate increased
Hypoaesthesia (reduced sense of touch or sensation)

50-59:

Fatigue (feeling of tiredness)
Somnolence (a state of near-sleep, a strong desire for sleep)
Migraine (headache)
Abnormal dreams
Insomnia (sleeplessness)
Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
Sleep paralysis (waking up and unable to move or speak)
Headache (pain in head)
Drug ineffective
Pneumonia

60+:

Fall
Back injury
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Dizziness
Hangover
Headache (pain in head)
Hyperacusis (disorder in loudness perception)
Hyperthyroidism (over activity of the thyroid gland)
Infection
Infusion related reaction

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 51 people, 72.86%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 29 people, 41.43%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 8.57%
Immunodeficiency Common Variable: 6 people, 8.57%
Pain: 4 people, 5.71%
Depression: 4 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Vivelle and Ritalin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously